Heart diseases: Latest News, Top Stories & Analysis

NEW HOPE, PA — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO) has reported new clinical evidence suggesting its atrioventricular interval modulation (AVIM) therapy may significantly improve heart function in patients with …

Regional

Windtree Therapeutics Unveils U.S. Exclusivity Strategy for Istaroxime

May 10, 2025May 8, 2025 - by Timothy Alexander

WARRINGTON, PA — Windtree Therapeutics, Inc. (NasdaqCM: WINT) announced its strategy to secure 7.5 years of U.S. exclusivity for istaroxime, its investigational treatment for cardiogenic shock, if approved by the …